1-7 of 7
Cosmina Hogea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Machine Learning Approach to Understand Real-World Treatment in Patients with Higher-Risk Myelodysplastic Syndromes

Vandana Priya, Vivek P. Vaidya, Smita Agrawal, Neeraj Singh, Kaveri Chatra, Dhaval Parmar, Raymond Yan, Rahul K. Das, Mahnoush Haririfar, Peter McMahon, Mellissa Williamson, Islam Sadek, Cosmina Hogea
Journal: Blood
Blood (2023) 142 (Supplement 1): 5100.
https://doi.org/10.1182/blood-2023-182241
Published: 2023
Journal Articles

Evaluation of Disparities in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patient Treatment Patterns in a Large US Health System

Kristin J. Moore, Nicole M. Engel-Nitz, Peter McMahon, Jason Beal, Teraneh Z. Jhaveri, Mellissa Williamson, Katherine Andrade, Christina Landis, Islam Sadek, Cosmina Hogea
Journal: Blood
Blood (2023) 142 (Supplement 1): 2434.
https://doi.org/10.1182/blood-2023-182031
Published: 2023
Journal Articles

A Patient-Centered Programmatic Approach for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the US Community Oncology Setting

James M. Rossetti, Rushir Choksi, Anupama Vasudevan, Simon Blanc, Dawn Brenneman, Brandon Wang, Peter McMahon, Jason Beal, Teraneh Z. Jhaveri, Mellissa Williamson, Cosmina Hogea
Journal: Blood
Blood (2023) 142 (Supplement 1): 5101.
https://doi.org/10.1182/blood-2023-186836
Published: 2023
Journal Articles

Patient, Caregiver, and Physician Perspectives on Communication in Diagnosing and Treating Higher-Risk Myelodysplastic Syndromes: A Qualitative Study

Melissa Culhane Maravic, Natalie Land, Nadya Prood, Kelly Birch, Claire Cagle, Suepattra G. May, Eduardo J. Sabate, Ngozi Afulezi, Teraneh Z. Jhaveri, Mindy Chen, Audrey Hassan, Islam Sadek, Cosmina Hogea
Journal: Blood
Blood (2023) 142 (Supplement 1): 5178.
https://doi.org/10.1182/blood-2023-181976
Published: 2023
Journal Articles

A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma and Prior Exposure to Daratumumab, an Immunomodulatory Agent, and a Proteasome Inhibitor

Natalie Boytsov, Anissa Cyhaniuk, Gary Leung, Feng Wang, Cosmina Hogea, Matthew Lee Smith, Pallavi Mudumby
Journal: Blood
Blood (2021) 138 (Supplement 1): 4019.
https://doi.org/10.1182/blood-2021-152230
Published: 2021
Journal Articles

A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma Following Sequential Treatment with Lenalidomide and a Proteasome Inhibitor

Natalie Boytsov, Anissa Cyhaniuk, Gary Leung, Feng Wang, Cosmina Hogea, Matthew Lee Smith, Pallavi Mudumby
Journal: Blood
Blood (2021) 138 (Supplement 1): 4963.
https://doi.org/10.1182/blood-2021-152731
Published: 2021
Journal Articles

Current Clinical Practice and Decision-Making in Multiple Myeloma Treatment in the United States of America: A Real-World Survey

Amanda Ribbands, Boris Gorsh, Abigail Bailey, Natalie Boytsov, Emily Luke, Annabel Lambert, Cosmina Hogea
Journal: Blood
Blood (2021) 138 (Supplement 1): 3001.
https://doi.org/10.1182/blood-2021-151281
Published: 2021